Pros and cons of new mesh repair devices for pelvic organ prolapse

Article

While new minimally invasive mesh repair devices for pelvic organ prolapse seem to offer high short-term cure rates (94%-100%) and low morbidity rates, the severity of some of the complications led the authors of a recent retrospective multicenter study performed in Scotland to call for additional rigorous evaluation of these devices and prompted the editors of the journal in which the study was published to remind readers that the possibility of such consequences needs to be part of fully informed consent.

While new minimally invasive mesh repair devices for pelvic organ prolapse seem to offer high short-term cure rates (94%-100%) and low morbidity rates, the severity of some of the complications led the authors of a recent retrospective multicenter study performed in Scotland to call for additional rigorous evaluation of these devices and prompted the editors of the journal in which the study was published to remind readers that the possibility of such consequences needs to be part of fully informed consent.

The study included 289 women undergoing surgical management of genital tract prolapse with either Gynecare or American Medical Systems prolapse repair mesh devices during the period from January 2005 to December 2006. Complications requiring surgery included bladder injury (1.6%), rectal injury (1.1%), and two women with serious vascular injuries. In terms of postoperative complications, one in 10 women had mesh eroding into their vagina, one in 20 women had buttock pain (5.2%), one woman had bladder erosion, and two women developed serious infections, which lead to necrotizing fasciitis in one of them. Five percent of the women had persistent prolapse at 3 months' follow-up.

Abdel-fattah M, Ramsay I, West of Scotland Study Group. Retrospective multicenter study of the new minimally invasive mesh repair devices for pelvic organ prolapse. BJOG. 2008;115:22-30.

Recent Videos
Supreme Court upholds mifepristone access: Implications for women's health | Image Credit: linkedin.com
The significance of the Supreme Court upholding mifepristone access | Image Credit: unchealth.org
One year out: Fezolinetant displays patient satisfaction for managing hot flashes | Image Credit: sutterhealth.org
Addressing maternal health inequities: Insights from CDC's Wanda Barfield | Image Credit: cdc.gov
Addressing racial and ethnic disparities in brachial plexus birth Injury | Image Credit: shrinerschildrens.org
Innovations in prenatal care: Insights from ACOG 2024 | Image Credit:  uofmhealth.org.
Unlocking therapeutic strategies for menopausal cognitive decline | Image Credit: uclahealth.org.
Navigating menopause care: Expert insights from ACOG 2024 | Image Credit: mayo.edu.
© 2024 MJH Life Sciences

All rights reserved.